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ABSTRACT 
Increased levels of the second messenger lipid diacylglycerol (DAG) induce downstream signaling events 
including the translocation of C1 domain-containing proteins toward the plasma membrane. Here, we 
introduce three light-sensitive DAGs, termed PhoDAGs, which feature a photoswitchable acyl chain. The 
PhoDAGs are inactive in the dark and promote the translocation of proteins that feature C1 domains 
towards the plasma membrane upon a flash of UV-A light. This effect is quickly reversed after the 
termination of photostimulation or by irradiation with blue light, permitting the generation of oscillation 
patterns. Both protein kinase C and Munc13 can thus be put under optical control. PhoDAGs control 
vesicle release in excitable cells, such as mouse pancreatic islets and hippocampal neurons, and 
modulate synaptic transmission in Caenorhabditis elegans. As such, the PhoDAGs afford an 
unprecedented degree of spatiotemporal control, and are broadly applicable tools to study DAG signaling. 
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INTRODUCTION 
Diacylglycerol (DAG) is not only an integral component of plasma membrane phospholipids, but is also 
known for its role as a second messenger1. Cellular DAG concentrations are tightly regulated by enzymes 
including phospholipase C, as well as DAG lipases and kinases2. The bulk of DAG originates from 
phosphatidylcholine, or the phospholipase C-mediated hydrolysis of phosphoinositides. Rapid changes in 
DAG levels occur following the extracellular stimulation of receptors3. Over 50 different DAGs have been 
identified in humans4, and the length and degree of unsaturation of the lipid chains determines the 
biophysical and pharmacological properties of individual DAG species5.  
 DAGs interact with both transmembrane and soluble proteins, and are known to activate 
Transient Receptor Potential (TRP) cation channels, including TRPC3 and TRPC66. Importantly, DAG 
generation also triggers the translocation towards the plasma membrane of a number of proteins that 
contain C1 domains7. These small, highly conserved, zinc-binding protein domains were originally 
characterized as the DAG-sensing regulatory elements of the protein kinase C (PKC) family8. 
C1-mediated translocation plays a key role in the activation of various other factors, including kinases and 
nucleotide exchange factors2. DAGs were also reported to affect the protein machinery involved in 
synaptic transmission and exocytosis2,9. Thus, a tool which enables reversible control of C1 domain 
translocation would be widely applicable towards the control of intra- and intercellular signaling. 
 Precision pharmacological manipulation of lipid signaling is often difficult due to the restricted 
localization and diffusion of these hydrophobic molecules. Experimentally, the activation of C1 domain-
containing proteins is usually achieved by addition of bryostatins or phorbol-esters, which can be viewed 
as highly potent DAG mimics10. So far, the greatest control over DAG concentrations has been achieved 
with the photochemical uncaging of DAGs, such as caged 1,2-O-dioctanoyl-sn-glycerol (cg-1,2-DOG)11. 
However, once triggered, the activity cannot be switched OFF and the decay of the DAG signal depends 
on its metabolism or diffusion from the cell. Alternatively, chemical dimerizers12,13 or optogenetic 
techniques14 may be employed to modulate the levels of signaling lipids in cells on the addition of a small 
molecule or a flash of light, respectively. While these systems hold great promise for rapid switching 
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within signaling networks, they require recombinant expression of non-native proteins, and frequently 
depend on the presence of exogenous co-factors.  
Previously, we prepared a series of photoswitchable fatty acids, termed FAAzos15, which can 
mimic highly unsaturated fatty acids such as arachidonic acid. They are useful modular building blocks for 
synthetic incorporation into more elaborate photolipids. We now report the incorporation of the FAAzos 
into the DAG scaffold. The resulting photoswitchable DAGs, PhoDAGs, allow us to mimic the effects of 
natural DAGs in living cells with unprecedented kinetics and reversibility, especially in regards to pattern 
formation. 
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RESULTS 
Design and synthesis of photoswitchable DAGs 
The design of the PhoDAGs was guided by our previous work which suggested that the azobenzene 
derivative FAAzo-4 (Fig. 1a), in its cis-configuration, is able to mimic arachidonic acid15. Therefore, we 
synthesized PhoDAG-1 (1) as a photoswitchable analog of 2-O-arachidonyl-1-O-stearoyl-sn-glycerol 
(1,2-SAG) (Fig. 1b). PhoDAG-1 was intended to be less active with the azobenzene in the trans-form, 
and become more active upon isomerization to the cis-form with UV-A light. The more hydrophilic DAG 
derivatives, PhoDAG-2 (2) and PhoDAG-3 (3), were designed as cell-permeable analogs mimicking 
1,2-O-dioctanoyl-sn-glycerol (1,2-DOG)16, and contain shorter alkyl chains at the sn1 and sn2 positions, 
including the shorter chain azobenzene FAAzo-9 (4) (Supplementary Results, Supplementary Note 1).  
 PhoDAG-1 was synthesized in four steps in 57% overall yield (Supplementary Note 2a). When 
handled under ambient lighting conditions, PhoDAG-1 existed predominantly in its thermally stable 
trans-configuration and contained approximately 10% cis-isomer (Supplementary Note 2b). On 
irradiation with UV-A light (λ = 350–375 nm), PhoDAG-1 isomerized to its cis-configuration (Fig. 1c). 
Thermal back-relaxation of cis-PhoDAG-1 occurred with a τ-value of about 60 h in DMSO and 22 h in 
water, while blue irradiation increased the rate of isomerization from cis to trans. As such, PhoDAG-1 
behaves as a regular azobenzene, and can be switched over many cycles without fatigue (Fig. 1d). The 
remaining PhoDAGs were prepared in an analogous fashion (Supplementary Note 2c), and possessed 
comparable spectral characteristics to PhoDAG-1. 
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Figure 1 | Design and synthesis of photoswitchable diacylglycerols. (a) The chemical structures of 
the photoswitchable fatty acid FAAzo-4, 2-O-arachidonyl-1-O-stearoyl-sn-glycerol (1,2-SAG) and 
1,2-O-dioctanoyl-sn-glycerol (1,2-DOG). (b) The chemical structures of photoswitchable diacylglycerols 
PhoDAG-1 (1), PhoDAG-2 (2) and PhoDAG-3 (3). (c) The UV-Vis spectra of PhoDAG-1 (25 µM in 
DMSO) in its dark-adapted (black), UV-adapted (gray) and blue-adapted (blue) photostationary states. 
The absorbance at λ = 350 nm was plotted as a function of the irradiation wavelength, demonstrating that 
PhoDAG-1 existed primarily in its trans- and cis-configurations under blue and UV-A irradiation, 
respectively. (d) PhoDAG-1 was cycled between the two states over many cycles without fatigue. The 
absorbance at λ = 350 nm was plotted over multiple cycles of alternating UV-A and blue irradiation. 
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Optical control of C1 domain translocation 
We evaluated the effects of the PhoDAGs in HeLa cells transiently expressing a fluorescent C1 domain 
translocation reporter (C1-GFP)17,18 (Supplementary Table 1). Before the addition of any compound, 
C1-GFP was evenly distributed within the cytoplasm, and the application of trans-PhoDAG-1 did not 
affect its localization (Fig. 2a). Illumination with UV-A light (λ = 375 nm) and isomerization to cis-
PhoDAG-1 rapidly induced the translocation of C1-GFP towards the plasma membrane (Fig. 2b, 
Supplementary Fig. 1,2). After termination of the irradiation, C1-GFP diffused back into the cytoplasm, 
and translocation was again triggered on repeated stimulation (Fig. 2c). C1-GFP localization could be 
controlled with a high degree of spatial precision, as only cells that were directly irradiated were affected 
(Supplementary Fig. 3). Shorter UV-A pulses triggered a small and transient translocation, while longer 
periods of irradiation caused a larger and more sustained response (Fig. 2d), permitting the generation of 
oscillation patterns. After incubation with PhoDAG-1 followed by washing and removal of extracellular 
compound, translocation of C1-GFP was still observed on photoactivation (Supplementary Fig. 4a). The 
magnitude of the translocation induced by cis-PhoDAG-1 was comparable to that triggered by the 
uncaging of 1,2-DOG from its coumarin-caged form, cg-1,2-DOG (Supplementary Fig. 4b-d).  
Interestingly, PhoDAG-2 and PhoDAG-3 did not induce pronounced translocation of C1-GFP 
towards the plasma membrane. Instead, C1-GFP mostly accumulated on the inner membranes on 
PhoDAG application (Supplementary Fig. 5a). We monitored the localization and uptake of the 
PhoDAGs by exploiting the quenching of coumarin fluorescence by the azobenzene. We loaded HeLa 
cells with coumarin-labelled arachidonic acid (cg-AA) (Supplementary Fig. 5b), which localizes 
predominantly at the inner cellular membranes19. Application of PhoDAG-1 caused a slow but small 
decrease in the observed coumarin fluorescence (<20% of total, τ = 295 s) (Fig. 2e black, 
Supplementary Fig. 5c). In comparison, PhoDAG-3 caused a more rapid and significant decrease in 
coumarin fluorescence (>70% in total, τ = 85 s) (Fig. 2e gray, Supplementary Fig. 5d). These results 
suggest that PhoDAG-1 internalizes more slowly and remains trapped on the plasma membrane, while 
PhoDAG-3 quickly diffuses and accumulates at inner membranes. UV-A irradiation alone did not trigger 
the translocation of C1-GFP to the plasma membrane (Supplementary Fig. 6a). 
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PhoDAGs modulate intracellular Ca2+ levels in HeLa cells 
1,2-SAG was previously reported to increase intracellular Ca2+ ([Ca2+]i) levels in HeLa cells via activation 
of TRPC channels11. Using the genetically encoded Ca2+ sensor, R-GECO20, we observed that 
application of trans-PhoDAG-1 stimulated a small rise in [Ca2+]i (Fig. 2f). Upon isomerization to 
cis-PhoDAG-1, a much larger [Ca2+]i increase was observed. The TRPC channel blocker SKF-96365 
suppressed the rise in [Ca2+]i (Fig. 2f). After incubation with PhoDAG-1 followed by washing and removal 
of extracellular compound, an increase in [Ca2+]i was still observed on photoactivation (Fig. 2g, 
Supplementary Fig. 4a,6b). Incubation with cyclopiazonic acid, which depletes endoplasmic reticulum 
(ER) Ca2+ stores21, diminished the Ca2+ response (Fig. 2g, orange). NiCl2 in combination with a Ca2+-free 
extracellular buffer11 abolished the Ca2+ signal by preventing the entry of extracellular Ca2+ (Fig. 2g, gray). 
Together, these results suggest that cis-PhoDAG-1 promotes Ca2+ influx by activation of TRPC3 and/or 
TRPC6 channels, which in turn triggers Ca2+-induced Ca2+ release from intracellular stores. Interestingly, 
application and photoactivation of PhoDAG-3 only caused a small increase in [Ca2+]i, which was not 
affected by SKF-96365 (Supplementary Fig. 6c). 
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Figure 2 | PhoDAG-1 enables optical control of C1-GFP translocation and intracellular Ca2+ 
concentration in HeLa cells.  (a) Fluorescence images showed that PhoDAG-1 (150 µM) promotes 
reversible translocation of C1-GFP in HeLa cells towards the plasma membrane only after irradiation with 
λ = 375 nm light. (b) C1-GFP fluorescence intensity was measured across a representative cell (white 
line) loaded with PhoDAG-1 before (left image) and after (right image) illumination with λ = 375 nm light. 
All scale bars = 20 µM. (c) Translocation could be triggered over multiple cycles in the presence of 
PhoDAG-1, and was quantified by plotting the plasma membrane to cytoplasm (PM/CP) fluorescence 
intensity ratio of a representative cell. (d) Patterns of C1-GFP translocation were generated by irradiation 
at λ = 375 nm in the presence of PhoDAG-1 (n = 16, 2 experiments). (e) Fluorescence quenching 
dynamics of coumarin-labelled arachidonic acid (cg-AA, 100 µM) localized at the internal cell membranes 
after application of PhoDAG-1 (150 µM, n = 18, 2 experiments, black) or PhoDAG-3 (150 µM, n = 19, 2 
experiments, gray). (f) The TRPC channel blocker SKF-96365 (50 µM) decreased the Ca2+ influx on 
application and photoactivation of PhoDAG-1 (n = 54, 2 experiments, gray) when compared to PhoDAG-
1 alone (n = 16, 2 experiments, black). [Ca2+]i levels were monitored with the R-GECO Ca2+ sensor. (g) 
After incubation with PhoDAG-1 followed by the removal of extracellular compound, both cyclopiazonic 
acid (CPA, 50 µM, n = 64, 4 experiments, orange) and NiCl2 (5 mM) combined with a Ca2+-free 
extracellular buffer (0.1 mM EGTA, n = 73, 4 experiments, gray) reduced the Ca2+ response. Error bars 
were calculated as s.e.m. 
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Optical control of protein kinase C 
PKCs are a group of serine/threonine kinases that are involved in cell cycle regulation, proliferation, 
apoptosis and migration3. The PKC family is grouped into three different subtypes; conventional, novel 
and atypical, according to their cofactor requirements as determined by the regulatory elements linked to 
the kinase domain22. These regulatory domains allow different PKC isoforms to decode different signals 
at the plasma membrane, such as the generation of DAG.  
Novel PKCs, such as PKCδ, contain two C1 domains that orchestrate their activation alongside 
translocation toward the plasma membrane in a Ca2+-independent fashion23. In HeLa cells, 
PhoDAG-1 triggered translocation of fluorescently labeled PKCδ (PKCδ-RFP) towards the plasma 
membrane following a UV-A flash (Fig. 3a, Supplementary Movie 1). After termination of the irradiation, 
PKCδ-RFP translocated back to the cytosol with a τ-value of ~102 s (Fig. 3b). Translocation could be 
repeated over several cycles, however the magnitude of translocation often diminished with repeated 
UV-A flashes of the same duration (Supplementary Fig. 7a). To overcome this limitation, we developed 
a protocol that allowed us to perform many translocation cycles without a decrease in efficiency by 
increasing the irradiation time on each sequential photostimulation (Fig. 3c). Increasing the interval time 
between the UV-A pulses did not affect the translocation magnitude, suggesting that trans-PhoDAG-1 
metabolism was not a significant factor (Supplementary Fig. 7b).  
Conventional PKCs, such as PKCα, were also placed under optical control. PhoDAG-1 triggered 
the translocation of PKCα-GFP24 towards the plasma membrane on photoactivation 
(Supplementary Fig. 7c). In contrast to C1-GFP and PKCδ-RFP, PKCα-GFP translocation efficiency 
decreased quickly alongside Ca2+-influx on sequential photostimulations, reflecting its known Ca2+-
sensitivity22. 
 Although PKC translocation to the plasma membrane is normally associated with its activation25, 
translocation alone is not sufficient to conclude whether PhoDAG-1 can trigger PKC phosphorylation. To 
this end, we utilized the C kinase activity reporter (CKAR)26, which displays a decrease in FRET efficiency 
on phosphorylation (Fig. 3d,e). In line with previous reports26, the addition of 1,2-DOG 
(Supplementary Fig. 7d) to HeLa cells expressing CKAR caused a 5.5% increase in the CFP/YFP 
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fluorescence ratio, while the application of phorbol 12-myristate 13-acetate (PMA) 
(Supplementary Fig. 7e) caused a 4.8% increase. The application of trans-PhoDAG-1 did not cause a 
significant CKAR FRET change. However, a 4.4% increase in the CFP/YFP fluorescence ratio was 
observed on isomerization to cis, corresponding to 80% of the response evoked by 1,2-DOG (Fig. 3e). 
The application of trans-PhoDAG-3 also caused a small increase (2.2%) in the CFP/YFP ratio on 
application, and a further 2.0% increase was induced by photoactivation (Supplementary Fig. 7f,g). The 
overall response after the application and photoactivation of PhoDAG-3 was similar to that which was 
evoked by PhoDAG-1 (95%) or 1,2-DOG (76%). Interestingly, this effect was observed even in the 
absence of a clear translocation to the outer plasma membrane, suggesting that PKCδ-RFP could 
be activated on internal membranes as well. In all cases, the effect was reversed by the application of 
the broad-spectrum PKC inhibitors Gö-6983 or chelerythrine chloride (Fig. 3d,e, 
Supplementary Fig. 7d–h)27,28.  
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Figure 3 | PhoDAG-1 enables optical control of PKC. (a) Fluorescence images of HeLa cells 
expressing PKCδ-RFP showed that PhoDAG-1 (100 µM) triggered reversible translocation of PKCδ-RFP 
towards the plasma membrane on λ = 375 nm irradiation. Scale bar = 20 µM. (b) After photoactivation, 
PKCδ-RFP redistributed back to the cytoplasm (n = 19, 2 experiments). Translocation was quantified as 
the plasma membrane to cytoplasm (PM/CP) fluorescence intensity ratio. (c) Oscillations of PKCδ-RFP 
translocation were generated by sequential pulses of UV-A irradiation with increasing length (n = 11 cells, 
1 representative experiment). (d,e) PKC activation was evaluated in HeLa cells expressing PKCδ-RFP 
and the cytosolic C kinase activation reporter, CKAR26. (d) PhoDAG-1 (300 µM) triggered an increase in 
the cyan/yellow fluorescence emission ratio on isomerization to cis (n = 49, 3 experiments). (e) 
Photoactivation of PhoDAG-1 (n = 49, 3 experiments) produced a similar FRET change when compared 
to 1,2-DOG (300 µM, n = 32, 1 experiment) and PMA (5 µM, n = 31, 2 experiments). Application of 
Gö-6983 (10 µM, n = 49, 3 experiments) reversed this effect. The Mann-Whitney test was used to 
determine statistical significance. ns = not significant P>0.05, *P<0.005, ** P<0.001. Error bars were 
calculated as s.e.m. 
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Optical control of Ca2+ oscillations in β-cells 
In pancreatic β-cells, glucose induces oscillations in [Ca2+]i levels, the frequency of which strongly 
correlate with insulin secretion29. Similarly, DAG levels are known to oscillate in β-cells18, implicating a 
connection between glucose and lipid metabolism. The exact mechanism by which DAGs regulate insulin 
secretion remains elusive, however increased DAG levels were reported to terminate Ca2+ oscillations in 
the mouse insulinoma-derived β-cell line, MIN630,31. The addition of trans-PhoDAG-1 did not affect Ca2+ 
oscillations in MIN6 cells stimulated by a high glucose concentration (20 mM). Photoactivation with 
λ = 375 nm for 3 min caused a rapid decline in both the intensity and frequency of the Ca2+ oscillations 
(Fig. 4a,b), as well as the overall [Ca2+]i level (Supplementary Fig. 8a). In the majority of cells examined, 
this termination was transient and lasted on average 5 min. PhoDAG-3 behaved in a similar manner, but 
was active at a much lower concentration (Fig. 4c). 
Ca2+ oscillations in β-cells are driven by a dynamic interplay between voltage-gated ion channels. 
DAGs modulate the conductance of L-type voltage-activated Ca2+ channels (Cav) in mouse β-cells, and 
1,2-DOG is known to inhibit the whole-cell Cav current32. Using whole-cell patch clamp electrophysiology 
in MIN6 cells, we evaluated the effects of PhoDAGs on Cav conductance. Photoactivation of PhoDAG-3 
with UV-A light triggered a decrease in the Cav current (Fig. 4d, Supplementary Fig. 8b). This effect 
could be reversed by irradiation with blue light, and could be repeated over several cycles (Fig. 4e). 
Application of diltiazem, which blocks L-type Ca2+ channels, diminished the Cav current in a similar 
fashion (Supplementary Fig. 8c). UV-A irradiation alone did not affect the oscillatory behavior 
(Supplementary Fig. 9) or the Cav current (Supplementary Fig. 8c). 
 To compare the responses observed in MIN6 to those of primary β-cells, we cultured β-cells from 
dissociated mouse pancreatic islets. As in MIN6 cells, PhoDAG-3 triggered a light-dependent decrease in 
Ca2+ oscillation frequency (Fig. 4f) and the whole-cell Cav conductance (Fig. 4g). Surprisingly, in these 
cells cis-PhoDAG-1 caused an increase in the oscillation frequency and [Ca2+]i level (Fig. 4h). Patch 
clamp experiments revealed that, whereas photoactivation of PhoDAG-1 had little effect on Cav 
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conductance (Supplementary Fig. 10a), it caused a reduction in the conductance of delayed rectifier 
voltage-gated K+ channels (Kv) (Fig. 4i). Ablation of Kv has been shown to increase Ca2+ fluxes in β-cells 
by extending the action potential duration33. Similar effects can be also induced by arachidonic acid, 
which is known to block Kv2.1 channels34. In control experiments, the application of 1,2-DOG indeed 
decreased the magnitude of β-cell Cav conductance (Supplementary Fig. 10b), while the addition of 
arachidonic acid reduced the Kv current (Supplementary Fig. 10c). Neither UV-A nor blue-irradiation 
alone affected the Cav or Kv currents (Supplementary Fig. 10b,c). 
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Figure 4 | Optical control of Ca2+ oscillations in MIN6 and dissociated primary mouse β-cells. (a-c) 
Ca2+ oscillations in glucose-stimulated (20 mM) MIN6 cells were monitored using R-GECO. PhoDAG-1 
(300 µM) decreased [Ca2+]i levels on photoactivation with λ = 375 nm light, displayed as (a) individual 
[Ca2+]i traces from four representative cells, and (b) a statistical analysis of the oscillation frequency 
(n = 38, 3 experiments). Bar graphs represent the number of high intensity Ca2+ oscillations (>50% of 
highest transient in each trace) detected within every 60 s interval. (c) PhoDAG-3 (35 µM) also triggered 
a decrease in glucose-stimulated (20 mM) Ca2+ oscillations on photoactivation. (d) Isomerization to cis-
PhoDAG-3 (35 µM, n = 6) induced a decrease in whole-cell voltage-gated Ca2+ channel (Cav) current. (e) 
This effect was reversed by blue light and could be repeated over several cycles (n = 3). (f-i) In 
dissociated mouse β-cells: (f) cis-PhoDAG-3 (10 µM) caused a decrease in glucose-stimulated (11 mM) 
Ca2+ oscillations, corresponding to (g) a reduction in the Cav current (15 µM, n = 3). (h) In contrast, cis-
PhoDAG-1 (200 µM) led to an increase in the Ca2+ oscillation frequency. (i) A reduction in the delayed 
rectifier voltage-activated K+ channel (Kv) current was observed on isomerization to cis-PhoDAG-1 (n = 
3). Error bars were calculated as s.e.m. 
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Optical control of insulin secretion in pancreatic islets  
Islets of Langerhans are endocrine micro-organs comprised of hundreds of β-cells together with α-, δ- 
and pancreatic polypeptide cells35. We therefore examined whether responses in intact islets were similar 
to MIN6 and dissociated β-cells. In contrast to the effects observed in dissociated cells, intact mouse 
pancreatic islets pre-treated with either PhoDAG-1 (Fig. 5a,b) or PhoDAG-3 
(Supplementary Fig. 11a,b) responded to illumination with a marked and reproducible increase in the 
glucose-stimulated (11 mM) Ca2+ oscillation frequency. These results could be mimicked by the 
application of 1,2-DOG (Fig. 5c). Strikingly, islets treated with PhoDAG-1 were rendered light-responsive, 
displaying almost a 3-fold increase in insulin secretion (at 16.7 mM glucose) following photoactivation 
(Fig. 5d). UV-A irradiation alone did not significantly affect Ca2+ oscillation frequency or the amount of 
insulin secreted (Supplementary Fig. 11c,d). These results suggest that photoactivation of the PhoDAGs 
in intact pancreatic islets increases the Ca2+ oscillation frequency, and consequently elevates insulin 
secretion. 
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Figure 5 | Optical control of insulin secretion in intact mouse pancreatic islets. Glucose-stimulated 
(11 mM) Ca2+ oscillations in whole mouse pancreatic islets were monitored using Fluo-2. (a,b) 
Photoactivation of PhoDAG-1 (200 µM) triggered an increase in the oscillation frequency, displayed as 
(a) a representative trace from a single islet and (b) the average oscillation frequencies for several islets 
before and after λ = 350 nm irradiation (n = 9 recordings from 4 animals). (c) The application of 1,2-DOG 
(100 µM) led to an increase in the oscillation frequency (n = 8 recordings from 4 animals). (d) As 
determined by a homogeneous time-resolved fluorescence (HTRF) assay, cis-PhoDAG-1 (200 µM) at 
16.7 mM glucose led to a 3-fold increase in insulin secretion when compared to either trans-PhoDAG-1 or 
glucose-stimulated conditions (16.7 mM) alone. Similar effects were observed with 1,2-DOG (100 µM) 
(n = 3 assays from 6 animals). G3 = 3 mM glucose, G16.7 = 16.7 mM glucose. The Mann-Whitney test 
was used to determine statistical significance. ns = not significant, *P<0.05, **P<0.01. Error bars were 
calculated as s.e.m.  
20 
 
 
 
 
Optical control of synaptic transmission 
DAG is known as a regulator of neuronal activity9,36. Multiple downstream effectors of DAG signaling have 
been described37, including the PKC-dependent phosphorylation of Munc18 and the direct binding of 
DAG to Munc13 proteins, and have been linked to an increase in synaptic transmission38,39. Munc13s 
function as essential priming factors for synaptic vesicles, preparing them for fusion with the plasma 
membrane at the active zone, thereby facilitating the release of neurotransmitters into the synaptic cleft40–
42. We found that PhoDAG-1 could indeed trigger the translocation of the fluorescent translocation 
reporter Munc13-1-GFP towards the plasma membrane on photoactivation in HeLa cells over multiple 
cycles (Fig. 6a). The DAG-insensitive Munc13-1H567K-GFP mutant reporter40 did not respond to 
PhoDAG-1 (Supplementary Fig. 12).  
 We then examined the effects of all three PhoDAGs in primary cultures of mouse autaptic 
hippocampal neurons. In this case, PhoDAG-2 produced the most dramatic and reproducible effect on 
synaptic transmission. Synaptic transmission was measured by recording evoked excitatory postsynaptic 
currents (EPSCs) that were elicited by depolarization-induced action potentials. The initial EPSC 
amplitude was not affected by the presence of trans-PhoDAG-2 when compared to control neurons 
(Fig. 6b). However, on activation with λ = 365 nm light (30 s), we observed a prominent increase in the 
EPSC amplitude (Fig. 6c,d). This activation was sustained until inactivation with λ = 425 nm light (20 s), 
which triggered a rapid and significant decrease of the EPSC amplitude. This effect was absent in control 
neurons and could be repeated over multiple cycles with little to no decay in efficacy. The first activation 
of PhoDAG-2 led to a 1.19±0.07-fold increase of the EPSC amplitude, and was similar in the following 
two rounds of activation (1.19±0.1 fold and 1.18±0.07 fold) (Fig. 6e). Similarly, the first inactivation led to 
a 0.80±0.03 fold decrease in the EPSC amplitude, and was similar in the two following cycles (0.77±0.03 
and 0.76±0.03 fold respectively). We did not observe any change in the series resistance of the patch 
pipette during activation or inactivation of PhoDAG-2, which could have generated artifacts mimicking 
changes in the EPSC size (Supplementary Fig. 13). Similarly, PhoDAG-2 affected the frequency of 
spontaneous miniature postsynaptic currents (sEPSCs), pointing to an acute effect on the presynaptic 
release machinery (Fig. 6f). An increase in the sEPSC frequency was observed during periods of 
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activation, by 1.68±0.3, 1.55±0.4 and 1.62±0.2 fold over three rounds. Inactivation led to a decrease in 
the sEPSC frequency, by 0.65±0.1, 0.82±0.14, and 0.63±0.06 fold over three inactivation cycles, 
respectively. PhoDAG-3 produced similar results (Supplementary Fig. 14), however the variability of the 
response of the neurons to photoactivation was larger, and some neurons did not respond consistently 
during all rounds of activation/inactivation. PhoDAG-1 did not yield a consistent effect on synaptic 
transmission, likely due to its limited solubility at these high concentrations during incubation. 
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Figure 6 | PhoDAGs enable optical control of Munc13 and synaptic transmission. (a) In HeLa cells, 
PhoDAG-1 (150 µM) triggered reversible translocation of Munc13-1-GFP on photoactivation (n = 14, 3 
experiments). (b-f) Mouse hippocampal neurons were pre-incubated with PhoDAG-2 (500 µM, 20–25 
min, 37 ˚C) and excitatory post synaptic currents (EPSCs) were monitored by whole-cell voltage clamp 
electrophysiology. (b) trans-PhoDAG-2 (red, n = 8) did not affect the EPSC amplitude when compared to 
control neurons (black, n = 6). (c) Photoactivation of PhoDAG-2-treated neurons with λ = 365 nm light 
caused an increase in the EPSC amplitude, while deactivation with λ = 425 nm light reversed the effect. 
Shown are two neurons pre-incubated with PhoDAG-2 (red) and two control neurons (black). (d) 
Representative EPSC traces during activation and inactivation. Numbers indicate the EPSC number. 
Black traces are the EPSC before irradiation. (e,f) The normalized change in (e) the EPSC amplitude (red 
= PhoDAG-2, n = 8; black = vehicle, n = 6) and (f) sEPSC frequency (red = PhoDAG-2, n = 6; black = 
vehicle, n = 6) over six rounds of alternating activation and inactivation. Values for individual neurons are 
presented as open circles. (g) cis-PhoDAG-3 (1 mM) increased the rate of aldicarb-induced (1 mM) 
paralysis in Caenorhabditis elegans (n = 3 experiments, 20 animals each) when compared to animals 
exposed to trans-PhoDAG-3 (black). The paralysis rate was not affected by UV-A irradiation alone (blue, 
gray). (h) cis-PhoDAG-3 (1 mM) did not affect the rate of levamisole-induced (0.1 mM) paralysis in C. 
elegans (n = 3 experiments, 20 animals each) when compared to animals exposed to trans-PhoDAG-3 
(black). The paralysis rate was not affected by UV-A irradiation alone (blue, gray). A Mann-Whitney test 
was used to determine statistical significance. Error bars were calculated as s.e.m.  
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Control of Caenorhabditis elegans synaptic transmission 
Caenorhabditis elegans has been used extensively to study synaptic transmission43. At the 
neuromuscular junction, acetylcholine is released from cholinergic motor neurons and activates post-
synaptic cholinergic receptors of the body-wall muscles, inducing muscle contraction44. This process is 
terminated by the action of acetylcholinesterase. Sensitivity to aldicarb, an acetylcholinesterase inhibitor, 
is therefore commonly used to study synaptic transmission at the neuromuscular junction45. C. elegans 
become hypersensitive to aldicarb under conditions of excess acetylcholine release and display a faster 
onset of paralysis on exposure to the drug. Animals cultivated in the presence of cis-PhoDAG-3 (1 mM) 
showed a faster onset of paralysis induced by aldicarb (1 mM) as compared to animals cultivated only 
with ethanol (vehicle), with or without UV-A irradiation. Animals that were exposed to trans-PhoDAG-3 
showed no aldicarb hypersensitivity (Fig. 6g). To exclude post-synaptic effects (e.g. a possible 
PhoDAG-3-induced increase in the sensitivity of nicotinic acetylcholine receptors (nAChRs)), we used 
levamisole, which paralyzes animals due to hyperstimulation of muscle-specific nAChRs46,47. Animals 
grown in the presence of trans- or cis-PhoDAG-3 showed similar rates of levamisole-induced paralysis 
when compared to the vehicle controls (Fig. 6h). These results suggest that PhoDAG-3 affects pre-
synaptic transmission via modulating neurotransmitter release at the C. elegans neuromuscular junction. 
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DISCUSSION 
Here, we have demonstrated that the three PhoDAGs are versatile tools for controlling DAG 
signaling in a variety of experimental settings, and can even be applied in vivo. In all cases, the PhoDAGs 
were more potent in their cis-configuration, which is characterized by an increased molecular dipole 
moment and a more bent orientation48. We hypothesize that these changes mimic the transition from a 
less bent (ex. saturated) fatty acid, to a highly bent acyl chain like arachidonic acid. Effectively, this action 
mimics an increase in DAG levels on the membrane, potentially by making the headgroup more 
accessible for C1 domain binding. 
The length of each acyl chain is crucial, as hydrophobicity determines the localization and site of 
activity. We envision that PhoDAG-1 could be used as a general tool, by virtue of C1-fusion, to 
translocate other effector proteins towards the plasma membrane in a reversible manner. This approach 
can be extended to other kinases, lipases, or glycosidases, and could be invaluable in understanding how 
plasma membrane localization affects these proteins. Although the shorter chain PhoDAGs triggered 
translocation towards intracellular membranes preferentially, we demonstrated that this does not limit their 
utility in other settings. As photochromic ligands, they are applied to cells extracellularly without the need 
for genetic manipulation. Although their activity cannot be genetically targeted to specific organelles, 
activation can still be induced with the spatial precision of light, enabling specific cells or organelles to be 
activated on command. 
As with the metabolic generation of endogenous DAGs, the PhoDAGs stimulate a mosaic of 
effector proteins, similar to the downstream activation of the Gq-pathway. Although the small dynamic 
range of the CKAR sensor might limit our detection of PKC phosphorylation to quite low activation levels, 
our results in more complex systems suggest that the PhoDAGs indeed are capable of stimulating the cell 
in a physiologically relevant manner. In pancreatic β-cells, DAG signaling can be manipulated with a 
degree of precision and reproducibility currently unavailable to other chemical tools. These effects likely 
involve the activation of PKC alongside other partners including Munc13, affecting glucose-stimulated 
Ca2+ oscillations via effects on Kv/Cav channels, intracellular Ca2+ stores, the SNARE apparatus, granule 
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sensitivity and combinations thereof49. Similarly, our experiments in both hippocampal neurons and 
C. elegans suggest that the PhoDAGs increases neurotransmitter release by affecting the pre-synaptic 
release machinery. cis-PhoDAGs likely activate of Munc13 or cause the phosphorylation of Munc189,39, 
promoting vesicle release. Combined, these results demonstrate that the PhoDAGs are useful tools to 
study the effects of DAG on the exocytosis of both hormones and neurotransmitters. 
Most notably, the PhoDAGs revealed the cell and tissue-context of DAG signaling in pancreatic 
β-cells. When PhoDAGs are activated on β-cell inner membranes, an overall decrease in the Ca2+ 
oscillation frequency is observed. Conversely, DAG-activation on the outer plasma membrane 
preferentially leads to an increase in oscillation speed. Similar effects were also observed for the 
uncaging of arachidonic acid on the inner vs outer membranes of MIN6 cells19, which is not surprising 
given the metabolic connection between these two lipids. The divergent effects observed between MIN6 
and dissociated β -cells highlight the importance of the acyl chain length for DAG activity. This may stem 
from subtle differences in ion channel expression, membrane composition, and endogenous DAG levels 
between immortalized and primary cells. In the case of intact islets, a greater amount of extracellular 
matrix likely increases the surface availability of both long- and short-chain PhoDAGs, resulting in a 
reduced effect on the Cav channels. This work highlights the limitations of model cell lines, and may 
explain some of the contrasting reports in the literature on the effects of DAG in pancreatic β-cells. 
The PhoDAGs permit control over C1-containg proteins with unmatched spatiotemporal precision. 
They possess the main advantage of caged DAGs, as they can be applied to cells in the inactive trans-
configuration where they can be switched ON in seconds with a light stimulus. Importantly, these small 
molecule tools stand alone in their ability to switch OFF. This characteristic will enable researchers to 
mimic the natural oscillations observed in both DAG levels and PKC activation, in a fully time-controlled 
fashion26. As the PhoDAGs require high energy UV-A irradiation to become activated, their use could be 
partially restricted to primary research applications due to the cytotoxicity associated with high intensity 
UV-A light. Future studies will be directed towards preparing “red-shifted” PhoDAGs50, or those which can 
be activated by two-photon irradiation. This will permit the use of longer wavelength, and lower energy 
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irradiation for photoactivation. This deeper-penetrating light will increase the PhoDAGs applicability in 
more complex intact tissues, and as potential therapeutics. 
As a lipid precursor, DAG is incorporated into a collection of more complicated glycerolipids that 
serve as structural components, protein anchors, and signaling molecules. We expect that novel 
photolipids built around the DAG scaffold will emerge as useful tools to control a variety of proteins, 
alongside the membranes with which they interact. 
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ONLINE METHODS 
 
Cell culture 
HeLa Kyoto cells were grown in 1.0 g/L glucose Dulbecco's Modified Eagle Medium (DMEM, GIBCO, 
cat # 31885-023) supplied with 10% FBS (GIBCO, cat # 10270-106) and 0.1 mg/mL antibiotic Primocin 
(Invitrogen, cat # ant-pm-1). HeLa cells were first seeded in an 8-well Lab-Tek™ chambered coverslip 
(ThermoScientific # 155411) 24-48 h before transfection at 37 °C and 5% CO2. Transfection was carried 
out with FugeneHD (Promega, cat # E2311) in DMEM free of FBS and antibiotic according to the 
manufacturer's instructions. First, the media was aspirated and the wells were charged with DMEM media 
(200 µL per well). A transfection solution containing DMEM (20 µL per well), cDNA (300 ng total DNA per 
well) and FugeneHD (1.5 µL per well) was then added to each well of the 8-well Lab-Tek™. Cells were 
incubated at 37 °C and 5% CO2 for 20-24 h before the microscopy experiments were performed. 
 The mouse insulinoma derived cell line, MIN6, used in this study was initially developed and 
provided as a kind gift by Miyazaki et al.51. The cells were grown at 37 °C and 5% CO2 in high glucose 
Dulbecco's Modified Eagle Medium (DMEM, 41965-039, Life Technologies) supplied with 15% Fetal 
Bovine Serum (FBS, 10270098, Lifetechnologies), penicillin-streptomycin (Pen Strep, 100 U/mL, 
15140122, Lifetechnologies) and β-mercaptoethanol (70 µM, P07-05100, PAN-Biotech) that was always 
added freshly to the cell culture flasks. Cells were seeded in 8-well Lab-Tek™ microscope dishes 48–64 
h (to reach 50-80% confluence) prior to imaging. For Ca2+ imaging, MIN6 cells were transfected with 
cDNA coding for the R-GECO20 Ca2+ reporter, and cDNA coding for the C1-GFP17 DAG sensor (as a 
control) usually 24–48 h after seeding. A transfection cocktail of C1-GFP (200 ng per well) and R-GECO 
(200 ng per well) in Opti-MEM (20 µL per well, 31985-070, Life Technologies) and Lipofectamine2000® 
transfection reagent (1.5 µL per well, 11668030, Life Technologies) was added to each well of an 8-well 
Lab-Tek™ microscope dish loaded with 200 µL Opti-MEM (37 °C, immediately before the addition). After 
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24 h incubation at 37 °C and 8.5% CO2, the media was exchanged to culture media, followed by 
incubation for another 24 h before the microscopy experiments were performed. 
Culture of primary mouse pancreatic islets 
Islets were isolated from C57BL6 mice using collagenase digestion, as previously detailed52. Briefly, 
following euthanasia by cervical dislocation, the bile duct was injected with a collagenase solution 
(1 mg/mL) before digestion at 37 °C for 10 min and separation of islets using a Histopaque gradient 
(1.083 and 1.077 g/mL). Islets were cultured for 24–72 h in Roswell Park Memorial Institute (RPMI) 
medium supplemented with 10% fetal calf serum (FCS), 100 U/mL penicillin and 100 µg/mL streptomycin. 
Islets were dissociated into single β-cells using trypsin digestion for 5 min at 37 °C and allowed to attach 
to poly-L-lysine-coated and acid-etched coverslips. All animal work was regulated by the Home Office 
according to the Animals Act 1986 (Scientific Procedures) of the United Kingdom (PPL 70/7349, Dr 
Isabelle Leclerc), as well as EU Directive 2010/63/EU. 
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Laser scanning confocal microscopy 
 
The cells were incubated in 250 µL imaging buffer containing (in mM): 115 NaCl, 1.2 CaCl2, 1.2 MgCl2, 
1.2 K2HPO4, 20 HEPES, glucose (20 for MIN6, 11 for islets and β-cells unless otherwise stated), adjusted 
to pH 7.4 with NaOH at 37 °C and 5% CO2 for at least 10 min. Compounds were first solubilized in DMSO 
at a concentration of 10 mM. This stock (2-5 µL) was then diluted into imaging buffer (50 µL) and added 
directly to the well containing the cells in imaging buffer. 
 Imaging of HeLa, MIN6, or primary rodent pancreatic β-cells was performed cells was performed 
on one of two microscopes: 1) Olympus Fluoview 1200 with a 20x objective, or a 63x oil objective. GFP 
excitation was performed with λ = 488 nm laser at low laser power (<3%) and emission was collected at 
λ = 500–550 nm. CFP excitation was performed with a λ = 405 nm laser at low laser power and emission 
was collected at λ = 425–475 nm. For FRET experiments, YFP emission was collected at λ = 510–560 
nm. RFP/R-GECO excitation was performed with a λ = 559 nm laser at low laser power (<3%) and 
emission was collected at λ = 570-670 nm. Compound irradiation at λ = 375 nm was triggered using the 
quench function in the Olympus software. Photoactivation was carried out with λ = 375 nm laser at 100% 
intensity. 2) Zeiss Axiovert M200 coupled to a Yokogawa CSU10 spinning disk head and 10x and 20x 
objectives. Fluo-2 excitation was performed using a solid-state λ = 491 nm laser, and emission was 
collected using a highly sensitive back-illuminated EM-CCD (Hammamatsu C9100-13) at λ = 500–
550 nm. Photoactivation was carried out using an X-Cite 120 epifluorescence source and a λ = 350±20 
nm band-pass filter. Images were processed with Fiji software (http://fiji.sc/Fiji) and the resulting data was 
analyzed in Microsoft Excel, MATLAB and R. The data were then plotted with Igor Pro, Origin and R.   
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Quantification of insulin secretion 
Insulin secretion was measured using static incubation of 6-8 islets for 30 min at 37 °C in Krebs-HEPES 
bicarbonate solution containing (in mM): 130 NaCl, 3.6 KCl, 1.5 CaCl2, 0.5 MgSO4, 0.5 NaH2PO4, 
2 NaHCO3, 10 HEPES and 0.1% (wt/vol) bovine serum albumin, pH 7.453. Treatments were applied as 
indicated, and photoswitching performed at λ = 340±10 nm using a BMG Fluostar Optima platereader. 
Insulin concentration secreted into the supernatant was determined using a homogeneous time-resolved 
fluorescence (HTRF) assay (Cisbio), according to the manufacturer’s instructions and low-range protocol. 
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Whole-cell electrophysiology in MIN6 and dissociated β-cells 
MIN6 cells (passage 26–33) were cultured as described above at 37 °C and 5% CO2. For cell 
detachment, the medium was removed and the cells were washed with Ca2+-free PBS buffer and treated 
with trypsin for 5 min at 37 °C. The detached cells were diluted in growth medium and plated on acid-
etched coverslips in a 24-well plate. 50,000 cells were added to each well in 500 µL growth medium. The 
growth medium was exchanged every 48 h, and electrophysiological experiments were carried out 2–7 
days later.  
Whole cell patch clamp experiments were performed using a standard electrophysiology setup 
equipped with a HEKA Patch Clamp EPC10 USB amplifier and PatchMaster software (HEKA Electronik). 
Micropipettes were generated from “Science Products GB200-F-8P with filament” pipettes using a 
Narishige PC-10 vertical puller. The patch pipette resistance varied between 4–7 MΩ. For recording of the 
Ca2+-channel current54, the bath solution contained (in mM): 82 NaCl, 20 tetraethylammonium chloride, 
0.1 tolbutamide, 30 CaCl2, 5 CsCl, 1 MgCl2, 0.1 EGTA, 10 glucose, 5 HEPES (adjusted to pH 7.4 with 
NaOH). The intracellular solution contained (in mM): 102 CsCl, 10 tetraethylammonium chloride, 
0.1 tolbutamide, 10 EGTA, 1 MgCl2, 3 Na2ATP, 5 HEPES (adjusted to pH 7.4 with CsOH). In voltage 
clamp mode, voltage steps were applied to the cells from the baseline at –70 mV to +50 mV in 10 mV 
intervals for 0.5 s. All cells had a leak current below 15 pA on break-in at –70 mV. For recording of the Kv 
current, the bath solution contained (in mM): 119 NaCl, 2 CaCl2, 4.7 KCl, 10 HEPES, 1.2 MgSO4, 1.2 
KH2PO4, 14.4 glucose (adjusted to pH 7.3 with NaOH). The intracellular solution contained (in mM): 140 
KCl, 1 MgCl2, 10 EGTA, 10 HEPES, 5 MgATP (adjusted to pH 7.25 with KOH). The data was analyzed in 
Igor Pro using the Patcher`s Power Tools (MPI Göttingen) plugin. Current values were extrapolated and 
processed in Microscoft Excel, and the results were again plotted in Igor Pro. 
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Electrophysiology in mouse hippocampal neurons 
Microisland cultures of wild type mouse hippocampal neurons were prepared as described55. For 
experiments, a 12-well plate was filled with 480 µL/well of extracellular recording solution contained 
(in mM): 140 NaCl, 2.4 KCl, 10 HEPES, 10 glucose, 4 CaCl2, and 4 MgCl2 (320 mOsmol/L), and 20 µL of 
a 12.5 M stock solution of PhoDAG-2 or PhoDAG-3 in DMSO was added. For controls, 20 µL of DMSO 
were added. The coverslips containing day in vitro 14–16 neurons were broken and a piece was moved 
into one well in the 12 well plate. The neurons were incubated at 37 ºC, and 5% CO2 for 10 min with 
PhoDAG-3 and respective controls; or for 20–25 min for PhoDAG-2 and respective controls. Neurons 
were incubated with PhoDAG, and were whole-cell voltage clamped directly post-incubation. EPSCs were 
elicited by depolarization-induced action potentials at a frequency of 0.2 Hz. For vehicle controls, neurons 
from the same culture were incubated in DMSO for the same time. Beyond these times, we did not find a 
correlation between the length of incubation and the presence of an effect or its strength. Longer 
incubation periods of >1 h resulted in astrocyte death. In the case of PhoDAG-2 patching the incubated 
neurons was usually easier 1 h after the stock solution was diluted in the extracellular solution. 3–4 
coverslips were subsequently incubated in one well where either PhoDAG-2 or PhoDAG-3 were diluted. 
Whole-cell voltage clamp recordings were acquired using the Axon Multiclamp 700B amplifier, 
Digidata 1440A data acquisition system, and the pCLAMP 10 software (Molecular Devices). The standard 
internal solution contained (in mM): 136 KCl, 17.8 HEPES, 1 EGTA, 4.6 MgCl2, 4 NaATP, 0.3 Na2GTP, 
15 creatine phosphate, and 5 U/mL phosphocreatine kinase (315–320 mOsmol/liter), pH 7.4. Action 
potentials were stimulated at 0.2 Hz (by depolarizing the cell from –70 to 0 mV for 2 ms) to evoke 
excitatory post synaptic currents (EPSCs). The sEPSCs were derived from the traces where EPSCs were 
recorded (last 600 ms of a 1 s recording) and were recorded without tetrodotoxin (TTX). However, in the 
autapse-system, sEPSCs predominantly represent miniature EPSCs Light illumination was performed by 
a CoolLED pE-2 lamp that was fixed to the setup. Photoactivation was performed at λ = 365 nm (80% 
strength) and inactivation at λ = 425 nm (40% strength). The normalized responses following illumination 
were calculated by dividing by the averaged response before illumination. All analyses were performed 
using Axograph 1.4.3. 
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Aldicarb assay 
Caenorhabditis elegans wild-type (N2) strain was cultivated at 20 °C on nematode growth medium (NGM) 
plates seeded with E. coli strain OP50-156. A 100 mM stock solution of PhoDAG-3 was prepared in 100% 
Ethanol. For application to C.elegans, the stock solution was diluted to the working concentration of 1 mM 
PhoDAG-3 using OP50-1 and 200 µL of the resulting solution was applied to the NGM plate. For the 
vehicle control, an equivalent volume of 100% EtOH was used instead of the stock solution. L4 stage 
larvae were picked onto 1mM PhoDAG-3/EtOH NGM plates and left overnight. The young adult 
hermaphrodites were used on the following day for the aldicarb and levamisole-sensitivity assays45,47. The 
assay was performed in the dark, except for the picking and counting of animals which was performed 
under red light. To study aldicarb or levamisole sensitivity, 20 animals were transferred onto NGM plates 
containing 1 mM aldicarb (Sigma) or 0.1 mM tetramisole hydrochloride (Racemic form of levamisole, 
Sigma) and the fraction of animals paralysed was scored every 15 min by assessing movement following 
three gentle touches with a platinum wire. The animals were illuminated with UV-A light (366 nm, 
18 µW/mm2) provided by a UV-A lamp (Benda, Wiesloch, Germany) for the first 5 min after being placed 
on the aldicarb/levamsiole plates and then subsequently for the last 3 min of each 15 min time interval. 
The assays were performed blinded regarding the absence/presence of PhoDAG-3, and on the same day 
with the same batch of aldicarb or levamisole plates.  
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Data reporting and error analysis 
For imaging experiments, “n” is the number of measurements made (individual cells). The number of 
independent experiments included in each panel is also described in the figure caption. For 
electrophysiological experiments, “n” represents the number of cells analyzed, each of which constitute 
an individual experiment. For insulin secretion experiments, “n” represents the number of independent 
experiments performed. For experiments in C. elegans, "n" represents the number of animals used, the 
number of experiments is also described in the figure caption. For all figure panels, results are plotted as 
mean ±s.e.m., using "n" as the number of samples. Where appropriate the Mann-Whitney test was used 
to determine statistical significance. 
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Synthetic protocols 
All reagents and solvents were purchased from commercial sources (Sigma-Aldrich, TCI Europe N.V., 
Strem Chemicals, etc.) and were used without further purification unless otherwise noted. 
Tetrahydrofuran (THF) was distilled under a N2 atmosphere from Na/benzophenone prior to use. 
Triethylamine (NEt3), was distilled under a N2 atmosphere from CaH2 prior to use. Other dry solvents such 
as ethyl acetate (EtOAc), dichloromethane (CH2Cl2) and toluene (PhMe) were purchased from Acros 
Organics as "extra dry" reagents and used as received. Reactions were monitored by thin layer 
chromatography (TLC) on pre-coated, Merck Silica gel 60 F254 glass backed plates and the 
chromatograms were first visualized by UV-A irradiation at 254 nm, followed by staining with aqueous 
ninhydrin, anisaldehyde or ceric ammonium molybdate solution, and finally gentle heating with a heat 
gun. Flash silica gel chromatography was performed using silica gel (SiO2, particle size 40–63 µm) 
purchased from Merck. Synthetic procedures are described in Supplementary Notes 1-3. 
UV-Vis spectra were recorded using a Varian Cary 50 Bio UV-Visible Spectrophotometer with 
Helma SUPRASIL precision cuvettes (10 mm light path). All compounds were dissolved at a 
concentration of 25 µM in DMSO. Switching was achieved using a Polychrome V (Till Photonics) 
monochromator. The illumination was controlled using PolyCon3.1 software and the light was guided 
through a fiber-optic cable with the tip pointed directly into the top of the sample cuvette. An initial 
spectrum was recorded (dark adapted state, black) and then again following illumination at the λmax for 
the π–π* transition (λ = 350 nm) for 3 min (cis-adapted state, purple). A third spectrum was recorded after 
irradiation at the λmax for the n–π* transition (λ = 450 nm) for 3 min (trans-adapted state, blue). 
 All NMR spectra were measured on a BRUKER Avance III HD 400 equipped with a CryoProbe™. 
Multiplicities in the following experimental procedures are abbreviated as follows: s = singlet, d = doublet, 
t = triplet, q = quartet, quint = quintet, sext = sextet, hept = heptet, br = broad, m = multiplet. Proton 
chemical shifts are expressed in parts per million (ppm, δ scale) and are referenced to the residual 
protium in the NMR solvent (CDCl3: δ = 7.26). Carbon chemical shifts are expressed in ppm (δ scale) and 
are referenced to the carbon resonance of the NMR solvent (CDCl3: δ = 77.16). NOTE: Due to the 
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trans/cis equilibrium of some compounds containing an azobenzene functionality, more signals were 
observed in the 1H and 13C spectra than would be expected for the pure trans-isomer. Only signals for the 
major trans-isomer are reported, however the identities of the remaining peaks were verified by 2D 
COSY, HSQC and HMBC experiments. NMR spectra are displayed in Supplementary Note 4. 
 Infrared spectra (IR) were recorded as neat materials on a PERKIN ELMER Spectrum BX-59343 
instrument. For detection a SMITHS DETECTION DuraSam-plIR II Diamond ATR sensor was used. The 
measured wave numbers are reported in cm-1.   
 Low- and high-resolution EI mass spectra were obtained on a MAT CH7A mass spectrometer. 
Low- and high-resolution ESI mass spectra were obtained on a Varian MAT 711 MS instrument operating 
in either positive or negative ionization modes. 
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